Daqian Xu
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Mechanisms of cancer metastasis 7
-
- Cancer, Hypoxia, and Metabolism 8
- Cancer, Lipids, and Metabolism 6
- Co-authors
- Zhimin Lu (15 shared papers)Dongming Xing (6 shared papers)Ying Meng (6 shared papers)Xueli Bian (4 shared papers)Rui Liu (2 shared papers)Xu Qian (8 shared papers)Xinjian Li (7 shared papers)Linyong Du (7 shared papers)
- Journals
- Autophagy (3 papers)Biochemical Journal (3 papers)Molecular Cell (3 papers)Nature Communications (2 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Daqian Xu
46 papers receiving 3.0k citations
Daqian Xu's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 1.2k
- Molecular Biology 1.8k
- Biochemistry 153
- Physiology 75
- Epidemiology 509
Countries citing papers authored by Daqian Xu
This map shows the geographic impact of Daqian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daqian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daqian Xu more than expected).
Fields of papers citing papers by Daqian Xu
This network shows the impact of papers produced by Daqian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daqian Xu. The network helps show where Daqian Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Daqian Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipid metabolism and cancer Hit paper breakdown → | 2020 | 629 |
| 2 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Hit paper breakdown → | 2020 | 260 |
| 3 | 2016 | 171 | |
| 4 | 2020 | 166 | |
| 5 | 2021 | 158 | |
| 6 | 2018 | 146 | |
| 7 | 2018 | 145 | |
| 8 | 2019 | 144 | |
| 9 | 2019 | 119 | |
| 10 | 2020 | 117 | |
| 11 | 2014 | 73 | |
| 12 | 2015 | 70 | |
| 13 | 2019 | 64 | |
| 14 | 2016 | 59 | |
| 15 | Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation Hit paper breakdown → | 2024 | 49 |
| 16 | 2018 | 48 | |
| 17 | 2018 | 46 | |
| 18 | 2019 | 43 | |
| 19 | 2016 | 38 | |
| 20 | 2013 | 38 |
About Daqian Xu
Daqian Xu is a scholar working on Molecular Biology, Cancer Research, Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), Mechanisms of cancer metastasis (7 papers), Cancer, Lipids, and Metabolism (6 papers), Diet, Metabolism, and Disease (5 papers), Cholesterol and Lipid Metabolism (5 papers), Lipid metabolism and biosynthesis (4 papers), Autophagy in Disease and Therapy (4 papers) and Oxidative Organic Chemistry Reactions (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.8k citations), Biochemistry (153 citations), Physiology (75 citations) and Epidemiology (509 citations). Daqian Xu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhimin Lu, Dongming Xing, Ying Meng, Xueli Bian, Rui Liu, Xu Qian, Xinjian Li, Linyong Du, Fei Shao and Yanhua Zheng. Their work appears in journals such as Autophagy, Biochemical Journal, Molecular Cell, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.